23andMe Faces NASDAQ Delisting And Numerous Lawsuits
SUNNYVALE, CALIFORNIA - FEBRUARY 01: A sign is posted in front of the 23andMe headquarters on February 01, 2024 in Sunnyvale, California. Genetic testing company 23andMe, once valued at $6 billion, is facing the possibility of delisting from NASDAQ as the company navigates numerous class action lawsuits (Photo by Justin Sullivan/Getty Images)

PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty Images23andMe Faces NASDAQ Delisting And Numerous Lawsuits, News Photo
23andMe Faces NASDAQ Delisting And Numerous Lawsuits Get premium, high resolution news photos at Getty ImagesProduct #:1978239010

$499$175
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Editorial #:
1978239010
Collection:
Getty Images News
Date created:
February 01, 2024
Upload date:
License type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
js2_0129_jclikwgd
Max file size:
3744 x 2496 px (12.48 x 8.32 in) - 300 dpi - 5 MB